Susan Shiff's most recent trade in Tvardi Therapeutics Inc. was a trade of 6,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tvardi Therapeutics Inc | Dr. Susan Shiff, M.B.A.,PhD | Director | 09 Jun 2026 | 6,000 | 6,000 | - | - | Stock Option (right to buy) | ||
| Tvardi Therapeutics Inc | Dr. Susan Shiff, M.B.A.,PhD | Director | 17 Apr 2025 | 12,000 | 12,000 | - | - | Stock Option (right to buy) | ||
| Tvardi Therapeutics Inc | Susan Shiff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 195,000 | 195,000 | - | - | Stock Option (Right to Buy) | |
| Tvardi Therapeutics Inc | Susan Shiff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 150,647 | 202,085 (0%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Susan Shiff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 44,961 | 44,961 | - | - | Stock Option (Right to Buy) | |
| Tvardi Therapeutics Inc | Susan Shiff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 32,362 | 51,438 (0%) | 0% | 0 | Common Stock | |
| Tvardi Therapeutics Inc | Susan Shiff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 16,996 | 16,996 | - | - | Stock Option (Right to Buy) | |
| Tvardi Therapeutics Inc | Susan Shiff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 11,876 | 19,076 (0%) | 0% | 0 | Common Stock |